The Motley Fool Previous Page

2-Star Stocks Poised to Plunge: Arena Pharmaceuticals?

Brian D. Pacampara
May 4, 2012

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, clinical-stage biotechnology company Arena Pharmaceuticals (Nasdaq: ARNA  ) has received a distressing two-star ranking.

With that in mind, let's take a closer look at Arena's business and see what CAPS investors are saying about the stock right now.

Arena facts

Headquarters (founded) San Diego, Calif. (1997)
Market Cap $499.8 million